Examination Report |
1 | TM-1 | 22 Jun 2012 |
2 | Reply to Exam Report (MIS-R) | 26 Nov 2014 |
3 | Certificate | 18 Nov 2016 |
4 | Journal Copy | 20 Dec 2016 |
5 | TM-P(ALTER OR SUBSTITUTE OF ADDRESS FOR SERVICE IN INDIA) | 17 Jun 2022 |
5 | TM-R(RENEWAL OF TRADE MARK) | 17 Jun 2022 |
6 | TM-P(CHANGE NAME OF REGISTERED PROP/USER) | 17 Jun 2022 |
6 | TM-R(RENEWAL OF TRADE MARK) | 17 Jun 2022 |
7 | TM-P(CHANGE NAME OF REGISTERED PROP/USER) | 17 Jun 2022 |
8 | TM-P(ALTER OR SUBSTITUTE OF ADDRESS FOR SERVICE IN INDIA) | 17 Jun 2022 |
8 | TM-P(CHANGE NAME OF REGISTERED PROP/USER) | 17 Jun 2022 |
1 | Hearing Notice (Show Cause) | 2419754 | 1263334 | 07 Oct 2015 |
2 | Tribunal ABA Notice for : 2352354 | 2502568 | 1282074 | 05 Nov 2015 |
3 | O3 NOTICE | 13232027 | 5560683 | 24 Mar 2022 |
4 | RENEWAL INTIMATION LETTER | 13676025 | 20 Jun 2022 |
The application for Strimide was made on 22 June 2012.
The trademark applicant for Strimide is STRIDES PHARMA SCIENCE.
Strimide is applied in class(es) 5.
Application for Strimide is on Registered stage.
Application Id allotted to Strimide is 2352354.
Trademark agent or attorney for the application is Altacit Global.
Strimide filed with the Intellectual property office as a DEVICE.